NCODA Announces Inaugural Class of Fellow of NCODA (FNCODA) Recipients
Published Date:
New professional designation recognizes sustained leadership, distinguished service, and meaningful contributions to NCODA and the advancement of oncology care.
October 29, 2026 – NCODA is pleased to announce the inaugural class of Fellow of NCODA (FNCODA) recipients, formally introduced today during the 2026 NCODA International Fall Summit in Orlando, Florida.
The FNCODA designation is a new, lifelong professional distinction recognizing NCODA members who have demonstrated sustained commitment to the organization’s mission and made meaningful contributions to oncology practice through leadership, education, mentorship, engagement, global impact, and service.
The inaugural Class of 2026 represents a distinguished group of professionals whose dedication, expertise, and contributions have helped shape NCODA, strengthen the multidisciplinary oncology community, and advance patient-centered, integrated cancer care.
“These individuals have played an important role in shaping NCODA into the organization it is today,” said Mike Reff, RPh, MBA, Founder and Executive Director of NCODA. “Through their leadership, expertise, and commitment to our Mission, they have helped strengthen our community and advance the way we care for patients with cancer. Establishing the FNCODA designation allows us to formally recognize their lasting contributions and the example they set for future leaders in oncology.”
NCODA extends its congratulations to the inaugural Fellows, whose contributions reflect the values of collaboration, leadership, education, mentorship, and service that are central to the organization’s mission.
The introduction of the inaugural class marks the beginning of a new tradition for NCODA, recognizing individuals whose leadership and service have helped advance the organization and its Mission of empowering medically integrated oncology teams to deliver positive, patient-centered outcomes.
Please join NCODA in congratulating the inaugural Class of 2026 and thanking these individuals for their continued dedication to advancing oncology care.
